Answers are grounded in this paper and cite their sources.
Genetic downregulation alters circadian period through glycolytic enzymes like pyruvate kinase, indicating metabolic influence.
Abstract The circadian clock generates approximately 24-hour rhythms in behavior and physiology enabling organisms to anticipate daily environmental fluctuations. Circadian clock and glucose metabolism are tightly interconnected, and their disruption commonly co-occurs in aging and disease. However, how glucose hypometabolism specifically impacts circadian rhythm remains unclear. Here, we investigated this relationship by genetically downregulating key glycolytic enzymes - Hexokinase-C (Hex-C), Phosphofructokinase (Pfk), and Pyruvate kinase (Pyk) - in Drosophila clock cells. Only Hex-C and Pyk knock-down (KD) altered circadian period in accordance with their mRNA reduction, inducing period lengthening and shortening, respectively. Notably, Pyk KD induced period shortening persisted in adult-specific KD (AKD), minimizing developmental confounds. Mechanistic analyses revealed that Pyk AKD reduced both PERIOD protein and Pigment-dispersing factor (PDF) levels. We identified TARANIS (TARA), a transcriptional coregulator recently shown to positively regulate PDF, as a crucial mediator of PYK's effect. Pyk AKD lowered tara mRNA and protein levels, whereas tara overexpression in Pyk AKD rescued both the short-period phenotype and reduced PDF levels. Together, our findings establish a novel PYK-TARA-PDF regulatory axis linking glycolytic enzyme activity to circadian neuropeptide output, providing mechanistic insight into how metabolic dysfunction contributes to circadian disruption associated with aging and neurodegenerative diseases.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2025) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: